2210.Se
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.3, indicating a significant reliance on debt financing. Despite a negative operating cash flow of -33.844 million, the company maintains a positive free cash flow of 62.547 million, which suggests that capital expenditures are being managed efficiently. The current ratio of 0.29 indicates a liquidity risk, as the company's current liabilities significantly exceed its current assets.
Profitability metrics show mixed results. The company's return on equity (ROE) is 4.8%, which is below the industry median of 6.2%, while its return on assets (ROA) is 1.07%, also below the industry median of 2.1%. This suggests that the company is underperforming its peers in terms of asset utilization and equity returns.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The company's revenue concentration in a single segment also limits its ability to offset performance declines in that area with growth in others.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no clear guidance for the next fiscal year. Historical revenue data shows a decline in gross profit, with a negative gross profit of -65.597 million, indicating potential cost overruns or pricing pressures. The company's capital expenditures of -12.65 million suggest a reduction in investment, which could impact long-term growth.
The company faces moderate liquidity risk, with a current ratio of 0.29 and a negative net cash position after subtracting total debt. The risk assessment indicates a low probability of dilution, with no significant dilution events in the near term. However, the company's reliance on debt financing and negative operating cash flow could increase financial risk if interest rates rise or credit conditions tighten.
Recent filings and transcripts do not indicate any major strategic shifts or new product launches. The company's 10-K filing highlights ongoing challenges in managing production costs and maintaining pricing power in a competitive market.
- The company is highly leveraged, with a debt-to-equity ratio of 2.3, indicating a significant reliance on debt financing.
- The company's ROE and ROA are below industry medians, suggesting underperformance in asset utilization and equity returns.
- Revenue is concentrated in a single business segment, increasing exposure to regional and sector-specific risks.
- The company's growth trajectory is uncertain, with no clear guidance for the next fiscal year and a decline in gross profit.
- The company faces moderate liquidity risk, with a current ratio of 0.29 and a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 2210.SE Market data — financials · 2026-05-26